Embecta (EMBC) Financials

$10.11 -0.02 (-0.20%)

Closing price 06/11/2025 04:00 PM Eastern

Extended Trading

$10.11 0.00 (0.00%)

As of 03:59 AM Eastern

Annual Income Statements for Embecta

This table shows Embecta's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	9/30/2022	9/30/2023	9/30/2024
Net Income / (Loss) Attributable to Common Shareholders	224	70	78
Consolidated Net Income / (Loss)	224	70	78
Net Income / (Loss) Continuing Operations	224	70	78
Total Pre-Tax Income	257	106	44
Total Operating Income	310	222	167
Total Gross Profit	775	750	735
Total Revenue	1,130	1,121	1,123
Operating Revenue	1,130	1,121	1,123
Total Cost of Revenue	355	371	388
Operating Cost of Revenue	355	371	388
Total Operating Expenses	465	528	568
Selling, General & Admin Expense	340	441	490
Research & Development Expense	67	85	79
Impairment Charge	59	2.50	0.00
Total Other Income / (Expense), net	-53	-116	-123
Interest & Investment Income	-46	-107	-112
Other Income / (Expense), net	-6.80	-8.80	-10
Income Tax Expense	33	35	-34
Basic Earnings per Share	$3.92	$1.23	$1.36
Weighted Average Basic Shares Outstanding	57.07M	57.33M	58.13M
Diluted Earnings per Share	$3.89	$1.22	$1.34
Weighted Average Diluted Shares Outstanding	57.07M	57.33M	58.13M
Weighted Average Basic & Diluted Shares Outstanding	57.07M	57.33M	58.13M
Cash Dividends to Common per Share	$0.15	-	$0.60

This table shows Embecta's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-17	35	14	15	6.00	20	29	15	15	0.00	24
Consolidated Net Income / (Loss)	-17	35	14	15	6.00	20	29	15	15	0.00	24
Net Income / (Loss) Continuing Operations	-17	35	14	15	6.00	20	29	15	15	0.00	24
Total Pre-Tax Income	-28	56	25	20	5.00	14	9.90	27	-7.00	-0.70	36
Total Operating Income	-3.00	89	56	51	26	46	39	56	26	29	63
Total Gross Profit	177	189	190	190	182	186	185	190	174	157	164
Total Revenue	275	276	277	286	282	277	287	273	286	262	259
Operating Revenue	275	276	277	286	282	277	287	273	286	262	259
Total Cost of Revenue	98	87	87	97	100	91	102	82	112	105	95
Operating Cost of Revenue	98	87	87	97	100	91	102	82	112	105	95
Total Operating Expenses	180	100	134	138	156	140	146	134	148	128	101
Selling, General & Admin Expense	103	83	112	116	130	120	128	114	128	108	93
Research & Development Expense	18	17	22	23	24	20	18	20	20	20	8.00
Total Other Income / (Expense), net	-25	-33	-31	-31	-21	-31	-29	-29	-33	-29	-27
Interest & Investment Income	-22	-26	-27	-27	-28	-28	-28	-28	-29	-28	-27
Other Income / (Expense), net	-2.70	-7.10	-4.30	-4.20	6.80	-3.50	-1.50	-1.10	-4.20	-1.50	-0.40
Income Tax Expense	-10	21	11	4.90	-1.00	-5.80	-19	12	-22	-0.70	12
Basic Earnings per Share	($0.27)	$0.62	$0.24	$0.27	$0.10	$0.35	$0.50	$0.25	$0.26	$0.00	$0.40
Weighted Average Basic Shares Outstanding	57.07M	57.27M	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M
Diluted Earnings per Share	($0.29)	$0.61	$0.24	$0.26	$0.11	$0.35	$0.50	$0.25	$0.24	$0.00	$0.40
Weighted Average Diluted Shares Outstanding	57.07M	57.27M	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M
Weighted Average Basic & Diluted Shares Outstanding	57.07M	57.27M	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M

This table details how cash moves in and out of Embecta's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Net Change in Cash & Equivalents	0.00	331	-4.40	-52
Net Cash From Operating Activities	456	412	68	36
Net Cash From Continuing Operating Activities	456	412	68	36
Net Income / (Loss) Continuing Operations	415	224	70	78
Consolidated Net Income / (Loss)	415	224	70	78
Depreciation Expense	38	32	33	36
Amortization Expense	0.00	3.20	6.40	13
Non-Cash Adjustments To Reconcile Net Income	27	31	0.80	85
Changes in Operating Assets and Liabilities, net	-23	123	-43	-177
Net Cash From Investing Activities	-39	-24	-27	-16
Net Cash From Continuing Investing Activities	-39	-24	-27	-16
Purchase of Property, Plant & Equipment	-37	-24	-27	-16
Acquisitions	-2.40	-0.40	0.00	0.00
Net Cash From Financing Activities	-417	-48	-49	-73
Net Cash From Continuing Financing Activities	-417	-48	-49	-73
Repayment of Debt	0.00	-44	-9.50	-35
Payment of Dividends	0.00	-8.60	-34	-35
Issuance of Debt	0.00	1,450	0.00	0.00
Other Financing Activities, net	-417	-1,446	-4.80	-4.30
Effect of Exchange Rate Changes	0.00	-9.30	3.10	1.20

This table details how cash moves in and out of Embecta's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	39	54	-39	-29	9.10	-28	7.80	-25	-7.60	-58	-4.40
Net Cash From Operating Activities	58	60	-13	-9.30	30	-13	24	-2.10	27	-5.30	32
Net Cash From Continuing Operating Activities	58	60	-13	-9.30	30	-13	24	-2.10	27	-5.30	32
Net Income / (Loss) Continuing Operations	-17	35	14	15	6.00	20	29	15	15	0.00	24
Consolidated Net Income / (Loss)	-17	35	14	15	6.00	20	29	15	15	0.00	24
Depreciation Expense	7.50	7.20	8.00	8.10	9.30	8.80	9.00	8.90	9.50	9.40	9.00
Amortization Expense	1.30	1.60	1.60	1.60	1.60	2.00	2.80	3.80	4.60	4.60	4.70
Non-Cash Adjustments To Reconcile Net Income	110	-4.00	0.20	-34	39	24	54	-8.80	16	35	6.80
Changes in Operating Assets and Liabilities, net	-43	20	-37	0.20	-26	-68	-70	-21	-18	-54	-12
Net Cash From Investing Activities	-8.60	-4.70	-5.80	-6.80	-9.20	-2.70	-3.40	-9.70	-	-1.50	-0.10
Net Cash From Continuing Investing Activities	-8.60	-4.70	-5.80	-6.80	-9.20	-2.70	-3.40	-9.70	-	-1.50	-0.10
Purchase of Property, Plant & Equipment	-8.60	-4.70	-5.80	-6.80	-9.20	-2.70	-3.40	-9.70	-	-1.50	-0.10
Net Cash From Financing Activities	-7.10	-6.10	-21	-12	-9.70	-14	-12	-12	-37	-45	-37
Net Cash From Continuing Financing Activities	-7.10	-6.10	-21	-12	-9.70	-14	-12	-12	-37	-45	-37
Repayment of Debt	-8.00	-2.40	-2.40	-2.30	-2.40	-2.40	-2.40	-2.40	-27	-32	-27
Payment of Dividends	-8.60	0.00	-17	-8.60	-8.60	-8.60	-8.60	-8.60	-8.70	-8.80	-8.70
Other Financing Activities, net	9.50	-3.70	-1.10	-1.30	1.30	-2.50	-0.80	-0.50	-0.50	-4.00	-1.20
Effect of Exchange Rate Changes	-3.70	4.70	0.70	-0.70	-1.60	1.50	-1.30	-1.40	2.40	-5.50	1.20

This table presents Embecta's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	9/30/2022	9/30/2023	9/30/2024
Total Assets	1,086	1,214	1,285
Total Current Assets	665	749	761
Cash & Equivalents	331	326	268
Restricted Cash	-	0.20	6.70
Accounts Receivable	133	159	247
Inventories, net	123	152	172
Other Current Assets	78	111	69
Plant, Property, & Equipment, net	302	300	290
Total Noncurrent Assets	120	165	234
Goodwill	25	25	24
Noncurrent Deferred & Refundable Income Taxes	96	140	210
Total Liabilities & Shareholders' Equity	1,086	1,214	1,285
Total Liabilities	1,978	2,036	2,024
Total Current Liabilities	301	354	374
Short-Term Debt	9.50	9.50	9.50
Accounts Payable	108	127	134
Accrued Expenses	104	118	134
Current Deferred & Payable Income Tax Liabilities	27	34	27
Current Employee Benefit Liabilities	49	62	67
Other Current Liabilities	3.60	3.60	3.40
Total Noncurrent Liabilities	1,677	1,683	1,650
Long-Term Debt	1,598	1,594	1,565
Noncurrent Deferred & Payable Income Tax Liabilities	46	57	54
Other Noncurrent Operating Liabilities	33	32	30
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-891	-822	-738
Total Preferred & Common Equity	-891	-822	-738
Total Common Equity	-891	-822	-738
Common Stock	11	29	53
Retained Earnings	-577	-541	-499
Accumulated Other Comprehensive Income / (Loss)	-325	-309	-293

This table presents Embecta's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025
Period end date	6/30/2022	12/31/2022	3/31/2023	6/30/2023	12/31/2023	3/31/2024	6/30/2024	12/31/2024	3/31/2025
Total Assets	1,050	1,197	1,210	1,252	1,218	1,200	1,268	1,150	1,120
Total Current Assets	581	762	756	788	720	710	781	667	643
Cash & Equivalents	292	385	346	317	299	300	275	210	209
Restricted Cash	-	-	-	-	-	6.70	6.70	6.70	3.00
Accounts Receivable	119	143	153	190	206	167	243	221	203
Inventories, net	130	143	158	170	149	153	186	169	169
Other Current Assets	39	90	100	110	65	83	70	61	59
Plant, Property, & Equipment, net	376	314	314	309	301	293	291	259	257
Total Noncurrent Assets	94	121	140	156	197	196	195	223	219
Goodwill	25	24	24	25	24	24	24	23	23
Noncurrent Deferred & Refundable Income Taxes	-	97	116	131	173	172	171	200	196
Total Liabilities & Shareholders' Equity	1,050	1,197	1,210	1,252	1,218	1,200	1,268	1,150	1,120
Total Liabilities	1,897	2,033	2,033	2,062	2,011	1,969	2,031	1,918	1,856
Total Current Liabilities	229	370	358	386	327	310	371	298	259
Short-Term Debt	9.50	9.50	9.50	9.50	9.50	9.50	9.50	9.50	9.50
Accounts Payable	64	107	127	125	100	91	119	116	80
Accrued Expenses	90	157	147	160	122	120	142	127	123
Current Deferred & Payable Income Tax Liabilities	20	45	36	35	34	28	41	0.00	0.00
Current Employee Benefit Liabilities	41	49	36	52	57	59	56	43	44
Other Current Liabilities	3.60	3.60	3.60	3.60	3.70	3.70	3.40	3.40	3.40
Total Noncurrent Liabilities	1,669	1,663	1,675	1,676	1,685	1,659	1,661	1,620	1,597
Long-Term Debt	1,599	1,597	1,596	1,595	1,593	1,592	1,591	1,535	1,509
Noncurrent Deferred & Payable Income Tax Liabilities	37	33	47	49	61	36	39	56	59
Other Noncurrent Operating Liabilities	33	32	32	32	31	31	31	30	30
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-848	-836	-823	-809	-794	-770	-764	-769	-736
Total Preferred & Common Equity	-848	-836	-823	-809	-794	-770	-764	-769	-736
Total Common Equity	-848	-836	-823	-809	-794	-770	-764	-769	-736
Common Stock	6.40	13	19	24	34	40	47	59	66
Retained Earnings	-556	-551	-545	-539	-530	-510	-504	-508	-494
Accumulated Other Comprehensive Income / (Loss)	-298	-299	-296	-295	-298	-300	-306	-320	-308

This table displays calculated financial ratios and metrics derived from Embecta's official financial filings.

Metric	2022	2023	2024
Period end date	9/30/2022	9/30/2023	9/30/2024
Growth Metrics	-	-	-
Revenue Growth	-3.07%	-0.77%	0.21%
EBITDA Growth	-36.67%	-25.47%	-18.20%
EBIT Growth	-38.82%	-29.76%	-26.42%
NOPAT Growth	-34.58%	-45.32%	100.29%
Net Income Growth	-46.09%	-68.52%	11.22%
EPS Growth	-46.57%	-68.64%	9.84%
Operating Cash Flow Growth	-9.66%	-83.58%	-47.27%
Free Cash Flow Firm Growth	363.17%	-83.79%	142.68%
Invested Capital Growth	-35.17%	18.14%	23.53%
Revenue Q/Q Growth	0.00%	0.66%	0.38%
EBITDA Q/Q Growth	0.00%	19.12%	-3.47%
EBIT Q/Q Growth	0.00%	21.96%	-6.34%
NOPAT Q/Q Growth	0.00%	18.73%	43.18%
Net Income Q/Q Growth	0.00%	49.15%	12.34%
EPS Q/Q Growth	0.00%	48.78%	10.74%
Operating Cash Flow Q/Q Growth	-6.25%	-29.55%	-7.75%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	45.73%
Invested Capital Q/Q Growth	0.00%	-4.71%	1.35%
Profitability Metrics	-	-	-
Gross Margin	68.61%	66.91%	65.46%
EBITDA Margin	29.90%	22.46%	18.33%
Operating Margin	27.41%	19.76%	14.85%
EBIT Margin	26.81%	18.98%	13.93%
Profit (Net Income) Margin	19.80%	6.28%	6.97%
Tax Burden Percent	87.14%	66.60%	177.15%
Interest Burden Percent	84.74%	49.69%	28.24%
Effective Tax Rate	12.86%	33.40%	-77.15%
Return on Invested Capital (ROIC)	55.08%	35.10%	58.08%
ROIC Less NNEP Spread (ROIC-NNEP)	47.85%	29.06%	41.23%
Return on Net Nonoperating Assets (RNNOA)	-205.60%	-43.32%	-68.12%
Return on Equity (ROE)	-150.52%	-8.22%	-10.04%
Cash Return on Invested Capital (CROIC)	97.75%	18.47%	37.03%
Operating Return on Assets (OROA)	32.31%	18.49%	12.52%
Return on Assets (ROA)	23.86%	6.12%	6.26%
Return on Common Equity (ROCE)	-150.52%	-8.22%	-10.04%
Return on Equity Simple (ROE_SIMPLE)	-25.08%	-8.57%	-10.61%
Net Operating Profit after Tax (NOPAT)	270	148	295
NOPAT Margin	23.89%	13.16%	26.31%
Net Nonoperating Expense Percent (NNEP)	7.23%	6.04%	16.85%
Return On Investment Capital (ROIC_SIMPLE)	37.67%	18.87%	35.32%
Cost of Revenue to Revenue	31.39%	33.09%	34.54%
SG&A Expenses to Revenue	30.06%	39.32%	43.59%
R&D to Revenue	5.92%	7.60%	7.02%
Operating Expenses to Revenue	41.20%	47.14%	50.61%
Earnings before Interest and Taxes (EBIT)	303	213	157
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	338	252	206
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.37	0.73	0.72
Price to Earnings (P/E)	6.92	11.67	10.31
Dividend Yield	0.56%	4.18%	4.29%
Earnings Yield	14.44%	8.57%	9.70%
Enterprise Value to Invested Capital (EV/IC)	7.33	4.61	3.75
Enterprise Value to Revenue (EV/Rev)	2.50	1.87	1.88
Enterprise Value to EBITDA (EV/EBITDA)	8.37	8.34	10.24
Enterprise Value to EBIT (EV/EBIT)	9.33	9.87	13.47
Enterprise Value to NOPAT (EV/NOPAT)	10.47	14.23	7.13
Enterprise Value to Operating Cash Flow (EV/OCF)	6.85	31.00	59.05
Enterprise Value to Free Cash Flow (EV/FCFF)	5.90	27.03	11.19
Leverage & Solvency	-	-	-
Debt to Equity	-1.80	-1.95	-2.13
Long-Term Debt to Equity	-1.79	-1.94	-2.12
Financial Leverage	-4.30	-1.49	-1.65
Leverage Ratio	-6.31	-1.34	-1.60
Compound Leverage Factor	-5.35	-0.67	-0.45
Debt to Total Capital	224.46%	205.12%	188.26%
Short-Term Debt to Total Capital	1.33%	1.22%	1.14%
Long-Term Debt to Total Capital	223.14%	203.90%	187.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	-124.46%	-105.12%	-88.26%
Debt to EBITDA	4.76	6.37	7.65
Net Debt to EBITDA	3.78	5.07	6.32
Long-Term Debt to EBITDA	4.73	6.33	7.60
Debt to NOPAT	5.96	10.87	5.33
Net Debt to NOPAT	4.73	8.66	4.40
Long-Term Debt to NOPAT	5.92	10.80	5.30
Altman Z-Score	2.09	1.51	1.33
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.21	2.12	2.03
Quick Ratio	1.54	1.37	1.38
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	479	78	188
Operating Cash Flow to CapEx	1,746.61%	255.47%	225.95%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	1.21	0.97	0.90
Accounts Receivable Turnover	7.96	7.67	5.53
Inventory Turnover	2.95	2.70	2.40
Fixed Asset Turnover	3.00	3.72	3.80
Accounts Payable Turnover	4.38	3.16	2.98
Days Sales Outstanding (DSO)	45.84	47.58	65.96
Days Inventory Outstanding (DIO)	123.93	135.26	152.25
Days Payable Outstanding (DPO)	83.43	115.38	122.37
Cash Conversion Cycle (CCC)	86.34	67.46	95.83
Capital & Investment Metrics	-	-	-
Invested Capital	385	455	562
Invested Capital Turnover	2.31	2.67	2.21
Increase / (Decrease) in Invested Capital	-209	70	107
Enterprise Value (EV)	2,825	2,099	2,108
Market Capitalization	1,548	822	807
Book Value per Share	($15.41)	($14.34)	($12.80)
Tangible Book Value per Share	($15.84)	($14.77)	($13.21)
Total Capital	716	782	837
Total Debt	1,608	1,603	1,575
Total Long-Term Debt	1,598	1,594	1,565
Net Debt	1,277	1,277	1,301
Capital Expenditures (CapEx)	24	27	16
Debt-free, Cash-free Net Working Capital (DFCFNWC)	42	79	122
Debt-free Net Working Capital (DFNWC)	373	405	397
Net Working Capital (NWC)	364	396	387
Net Nonoperating Expense (NNE)	46	77	217
Net Nonoperating Obligations (NNO)	1,277	1,277	1,301
Total Depreciation and Amortization (D&A)	35	39	49
Debt-free, Cash-free Net Working Capital to Revenue	3.75%	7.01%	10.89%
Debt-free Net Working Capital to Revenue	33.04%	36.14%	35.30%
Net Working Capital to Revenue	32.20%	35.30%	34.46%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$3.92	$1.23	$1.36
Adjusted Weighted Average Basic Shares Outstanding	57.07M	57.33M	58.13M
Adjusted Diluted Earnings per Share	$3.89	$1.22	$1.34
Adjusted Weighted Average Diluted Shares Outstanding	57.07M	57.33M	58.13M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	57.07M	57.33M	58.13M
Normalized Net Operating Profit after Tax (NOPAT)	321	149	117
Normalized NOPAT Margin	28.43%	13.31%	10.40%
Pre Tax Income Margin	22.72%	9.43%	3.94%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	3.85%	48.86%	44.06%
Augmented Payout Ratio	3.85%	48.86%	44.06%

This table displays calculated financial ratios and metrics derived from Embecta's official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-4.70%	0.95%	-1.72%	2.66%	0.58%	3.64%	-4.75%	1.49%	-5.55%	-9.82%
EBITDA Growth	0.00%	-27.60%	-42.33%	-45.38%	1,303.23%	-41.66%	-18.72%	18.84%	-17.01%	-21.97%	53.94%
EBIT Growth	0.00%	-29.93%	-48.08%	-49.41%	671.93%	-48.59%	-26.51%	16.35%	-32.52%	-35.24%	65.78%
NOPAT Growth	0.00%	-43.61%	-62.10%	-52.88%	1,574.29%	14.78%	260.17%	-21.55%	-40.76%	-68.59%	-63.92%
Net Income Growth	0.00%	-64.37%	-82.41%	-75.64%	134.88%	-42.90%	106.43%	-3.29%	143.33%	-100.00%	-18.69%
EPS Growth	0.00%	-64.74%	-82.61%	-75.70%	137.93%	-42.62%	108.33%	-3.85%	118.18%	-100.00%	-20.00%
Operating Cash Flow Growth	-32.16%	-56.48%	-107.12%	-128.35%	-48.97%	-121.69%	286.92%	77.42%	-10.14%	59.54%	30.86%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	107.74%	0.00%	81.51%	106.36%	-256.10%	-127.94%	53.38%	-114.03%
Invested Capital Growth	0.00%	0.00%	0.00%	1.90%	18.14%	32.42%	20.32%	16.14%	23.53%	9.51%	8.55%
Revenue Q/Q Growth	-5.67%	0.40%	0.51%	3.25%	-1.47%	-1.63%	3.57%	-5.12%	4.99%	-8.46%	-1.11%
EBITDA Q/Q Growth	-97.02%	2,819.35%	-32.71%	-6.73%	-23.42%	21.38%	-6.25%	36.36%	-46.52%	14.13%	84.95%
EBIT Q/Q Growth	-106.12%	1,533.33%	-37.21%	-8.19%	-30.79%	28.83%	-10.24%	45.36%	-59.85%	23.64%	129.78%
NOPAT Q/Q Growth	-102.55%	2,753.22%	-42.98%	22.10%	-20.19%	106.57%	78.93%	-73.40%	-39.74%	9.54%	105.52%
Net Income Q/Q Growth	-127.56%	304.65%	-60.23%	8.57%	-60.53%	235.00%	43.78%	-49.13%	-0.68%	-100.00%	0.00%
EPS Q/Q Growth	-127.10%	310.34%	-60.66%	8.33%	-57.69%	218.18%	42.86%	-50.00%	-4.00%	-100.00%	0.00%
Operating Cash Flow Q/Q Growth	76.83%	4.14%	-121.52%	28.46%	418.28%	-144.26%	285.50%	-108.64%	1,366.67%	-119.92%	700.00%
Free Cash Flow Firm Q/Q Growth	100.00%	0.00%	-22.80%	107.39%	-230.26%	-56.51%	142.22%	-281.35%	-90.20%	67.99%	87.29%
Invested Capital Q/Q Growth	-17.81%	0.00%	13.29%	9.44%	-4.71%	12.08%	2.94%	5.64%	1.35%	-0.64%	2.04%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.42%	68.48%	68.50%	66.24%	64.49%	67.04%	64.55%	69.76%	60.75%	59.98%	63.36%
EBITDA Margin	1.13%	32.83%	21.98%	19.85%	15.43%	19.04%	17.24%	24.77%	12.62%	15.73%	29.42%
Operating Margin	-1.09%	32.21%	20.07%	17.93%	9.15%	16.41%	13.65%	20.51%	9.16%	10.96%	24.29%
EBIT Margin	-2.08%	29.63%	18.51%	16.46%	11.56%	15.15%	13.13%	20.11%	7.69%	10.39%	24.13%
Profit (Net Income) Margin	-6.26%	12.77%	5.05%	5.31%	2.13%	7.25%	10.06%	5.39%	5.10%	0.00%	9.07%
Tax Burden Percent	62.55%	62.75%	57.14%	75.62%	120.00%	140.56%	291.92%	54.44%	-208.57%	0.00%	65.64%
Interest Burden Percent	482.46%	68.67%	47.76%	42.68%	15.34%	34.05%	26.26%	49.27%	-31.82%	-2.57%	57.28%
Effective Tax Rate	0.00%	37.25%	42.86%	24.38%	-20.00%	-40.56%	-191.92%	45.56%	0.00%	0.00%	34.36%
Return on Invested Capital (ROIC)	-2.24%	117.06%	58.76%	31.90%	29.29%	57.81%	93.84%	24.21%	14.15%	15.90%	31.42%
ROIC Less NNEP Spread (ROIC-NNEP)	-3.42%	113.70%	55.94%	30.09%	27.34%	54.34%	87.14%	23.00%	13.86%	14.37%	30.06%
Return on Net Nonoperating Assets (RNNOA)	4.90%	-166.10%	-85.62%	-47.28%	-40.75%	-84.20%	-139.78%	-38.09%	-22.90%	-24.20%	-51.92%
Return on Equity (ROE)	2.66%	-49.04%	-26.86%	-15.38%	-11.46%	-26.39%	-45.94%	-13.89%	-8.75%	-8.31%	-20.49%
Cash Return on Invested Capital (CROIC)	124.26%	0.00%	0.00%	0.00%	18.47%	6.55%	29.47%	25.04%	37.03%	46.87%	22.19%
Operating Return on Assets (OROA)	-2.50%	27.63%	17.11%	15.93%	11.27%	14.08%	12.34%	17.86%	6.91%	9.72%	22.46%
Return on Assets (ROA)	-7.55%	11.90%	4.67%	5.14%	2.07%	6.74%	9.46%	4.79%	4.59%	0.00%	8.44%
Return on Common Equity (ROCE)	2.66%	-49.04%	-26.86%	-15.38%	-11.46%	-26.39%	-45.94%	-13.89%	-8.75%	-8.31%	-20.49%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-19.14%	-11.48%	-5.83%	0.00%	-6.97%	-9.12%	-9.13%	0.00%	-7.57%	-7.17%
Net Operating Profit after Tax (NOPAT)	-2.10	56	32	39	31	64	114	30	18	20	41
NOPAT Margin	-0.76%	20.21%	11.47%	13.56%	10.98%	23.06%	39.84%	11.17%	6.41%	7.67%	15.94%
Net Nonoperating Expense Percent (NNEP)	1.18%	3.36%	2.82%	1.81%	1.95%	3.47%	6.70%	1.21%	0.29%	1.53%	1.37%
Return On Investment Capital (ROIC_SIMPLE)	-0.29%	-	-	-	3.96%	7.91%	-	-	2.19%	2.59%	5.28%
Cost of Revenue to Revenue	35.58%	31.52%	31.50%	33.76%	35.51%	32.96%	35.45%	30.24%	39.25%	40.02%	36.64%
SG&A Expenses to Revenue	37.55%	30.14%	40.45%	40.41%	46.08%	43.35%	44.50%	41.76%	44.67%	41.28%	35.98%
R&D to Revenue	6.52%	6.13%	7.98%	7.90%	8.37%	7.28%	6.41%	7.49%	6.92%	7.75%	3.09%
Operating Expenses to Revenue	65.51%	36.27%	48.43%	48.30%	55.34%	50.63%	50.91%	49.25%	51.59%	49.03%	39.07%
Earnings before Interest and Taxes (EBIT)	-5.70	82	51	47	33	42	38	55	22	27	63
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3.10	91	61	57	44	53	50	68	36	41	76
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.37	1.23	1.38	1.07	0.73	0.93	0.67	0.64	0.72	1.08	0.69
Price to Earnings (P/E)	6.92	8.59	16.32	25.22	11.67	18.84	10.76	10.34	10.31	20.63	14.04
Dividend Yield	0.56%	1.25%	1.67%	2.89%	4.18%	4.12%	4.57%	4.80%	4.29%	2.91%	4.71%
Earnings Yield	14.44%	11.64%	6.13%	3.96%	8.57%	5.31%	9.29%	9.67%	9.70%	4.85%	7.12%
Enterprise Value to Invested Capital (EV/IC)	7.33	6.74	6.42	5.19	4.61	4.60	3.90	3.68	3.75	4.52	3.59
Enterprise Value to Revenue (EV/Rev)	2.50	2.33	2.50	2.23	1.87	2.09	1.81	1.82	1.88	2.28	1.90
Enterprise Value to EBITDA (EV/EBITDA)	8.37	8.56	10.83	11.73	8.34	10.96	10.12	9.56	10.24	13.01	9.26
Enterprise Value to EBIT (EV/EBIT)	9.33	9.69	12.70	14.21	9.87	13.56	12.86	12.20	13.47	17.84	12.30
Enterprise Value to NOPAT (EV/NOPAT)	10.47	11.29	15.76	19.94	14.23	15.21	8.90	9.88	7.13	8.46	12.30
Enterprise Value to Operating Cash Flow (EV/OCF)	6.85	7.78	20.26	25.78	31.00	0.00	65.08	52.70	59.05	58.11	40.15
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	27.03	80.01	14.47	15.78	11.19	10.09	16.85
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-1.80	-1.92	-1.95	-1.98	-1.95	-2.02	-2.08	-2.10	-2.13	-2.01	-2.06
Long-Term Debt to Equity	-1.79	-1.91	-1.94	-1.97	-1.94	-2.01	-2.07	-2.08	-2.12	-2.00	-2.05
Financial Leverage	-1.43	-1.46	-1.53	-1.57	-1.49	-1.55	-1.60	-1.66	-1.65	-1.68	-1.73
Leverage Ratio	-6.31	-1.43	-1.47	-1.39	-1.34	-1.48	-1.51	-1.60	-1.60	-1.52	-1.54
Compound Leverage Factor	-30.44	-0.98	-0.70	-0.59	-0.21	-0.50	-0.40	-0.79	0.51	0.04	-0.88
Debt to Total Capital	224.46%	208.51%	205.07%	201.80%	205.12%	198.10%	192.53%	191.29%	188.26%	199.15%	194.10%
Short-Term Debt to Total Capital	1.33%	1.23%	1.21%	1.19%	1.22%	1.17%	1.14%	1.14%	1.14%	1.23%	1.21%
Long-Term Debt to Total Capital	223.14%	207.28%	203.86%	200.60%	203.90%	196.92%	191.39%	190.15%	187.12%	197.92%	192.88%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-124.46%	-108.51%	-105.07%	-101.80%	-105.12%	-98.10%	-92.53%	-91.29%	-88.26%	-99.15%	-94.10%
Debt to EBITDA	4.76	5.30	6.21	7.59	6.37	7.49	7.90	7.50	7.65	7.95	6.87
Net Debt to EBITDA	3.78	4.03	4.87	6.09	5.07	6.09	6.39	6.18	6.32	6.83	5.91
Long-Term Debt to EBITDA	4.73	5.27	6.17	7.55	6.33	7.44	7.86	7.46	7.60	7.90	6.83
Debt to NOPAT	5.96	6.99	9.04	12.91	10.87	10.39	6.95	7.75	5.33	5.17	9.12
Net Debt to NOPAT	4.73	5.31	7.09	10.36	8.66	8.45	5.62	6.39	4.40	4.44	7.85
Long-Term Debt to NOPAT	5.92	6.95	8.98	12.84	10.80	10.33	6.91	7.71	5.30	5.13	9.07
Altman Z-Score	1.15	1.31	1.28	1.14	1.02	1.12	1.08	1.07	0.99	1.18	1.18
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.21	2.06	2.11	2.04	2.12	2.20	2.29	2.11	2.03	2.24	2.48
Quick Ratio	1.54	1.43	1.40	1.32	1.37	1.55	1.50	1.40	1.38	1.44	1.59
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-330	-405	30	-39	-61	26	-47	-89	-28	-3.61
Operating Cash Flow to CapEx	674.42%	1,285.11%	-224.14%	-136.76%	321.74%	-485.19%	714.71%	-21.65%	0.00%	-353.33%	31,800.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.21	0.93	0.92	0.97	0.97	0.93	0.94	0.89	0.90	0.94	0.93
Accounts Receivable Turnover	7.96	7.79	7.32	7.20	7.67	6.42	7.08	5.16	5.53	5.19	5.84
Inventory Turnover	2.95	2.48	2.28	2.45	2.70	2.57	2.51	2.11	2.40	2.52	2.45
Fixed Asset Turnover	3.00	3.55	3.57	3.25	3.72	3.65	3.73	3.73	3.80	3.95	3.92
Accounts Payable Turnover	4.38	3.33	2.84	3.90	3.16	3.63	3.58	3.09	2.98	3.73	4.62
Days Sales Outstanding (DSO)	45.84	46.87	49.83	50.69	47.58	56.86	51.52	70.71	65.96	70.33	62.48
Days Inventory Outstanding (DIO)	123.93	146.98	159.74	148.87	135.26	142.25	145.48	172.88	152.25	144.75	149.18
Days Payable Outstanding (DPO)	83.43	109.57	128.53	93.60	115.38	100.44	101.99	118.14	122.37	97.91	78.94
Cash Conversion Cycle (CCC)	86.34	84.28	81.05	105.96	67.46	98.67	95.00	125.45	95.83	117.18	132.73
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	385	385	437	478	455	510	525	555	562	559	570
Invested Capital Turnover	2.93	5.79	5.12	2.35	2.67	2.51	2.36	2.17	2.21	2.07	1.97
Increase / (Decrease) in Invested Capital	0.00	385	437	8.90	70	125	89	77	107	49	45
Enterprise Value (EV)	2,825	2,596	2,800	2,478	2,099	2,346	2,050	2,039	2,108	2,528	2,048
Market Capitalization	1,548	1,375	1,541	1,191	822	1,042	755	721	807	1,200	741
Book Value per Share	($15.41)	($14.65)	($14.36)	($14.13)	($14.34)	($13.78)	($13.37)	($13.24)	($12.80)	($13.23)	($12.66)
Tangible Book Value per Share	($15.84)	($15.08)	($14.78)	($14.56)	($14.77)	($14.20)	($13.78)	($13.66)	($13.21)	($13.63)	($13.06)
Total Capital	716	771	783	795	782	809	832	837	837	775	782
Total Debt	1,608	1,607	1,606	1,605	1,603	1,602	1,601	1,600	1,575	1,544	1,519
Total Long-Term Debt	1,598	1,597	1,596	1,595	1,594	1,593	1,592	1,591	1,565	1,535	1,509
Net Debt	1,277	1,221	1,259	1,287	1,277	1,304	1,295	1,319	1,301	1,328	1,306
Capital Expenditures (CapEx)	8.60	4.70	5.80	6.80	9.20	2.70	3.40	9.70	0.00	1.50	0.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	42	16	62	94	79	104	103	138	122	162	181
Debt-free Net Working Capital (DFNWC)	373	401	408	411	405	402	409	420	397	379	394
Net Working Capital (NWC)	364	391	399	402	396	393	400	410	387	369	384
Net Nonoperating Expense (NNE)	15	21	18	24	25	44	86	16	3.74	20	18
Net Nonoperating Obligations (NNO)	1,277	1,221	1,259	1,287	1,277	1,304	1,295	1,319	1,301	1,328	1,306
Total Depreciation and Amortization (D&A)	8.80	8.80	9.60	9.70	11	11	12	13	14	14	14
Debt-free, Cash-free Net Working Capital to Revenue	3.75%	1.41%	5.52%	8.42%	7.01%	9.24%	9.06%	12.34%	10.89%	14.61%	16.79%
Debt-free Net Working Capital to Revenue	33.04%	35.93%	36.49%	36.93%	36.14%	35.85%	36.12%	37.53%	35.30%	34.17%	36.46%
Net Working Capital to Revenue	32.20%	35.07%	35.64%	36.08%	35.30%	35.01%	35.28%	36.68%	34.46%	33.31%	35.58%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.27)	$0.62	$0.24	$0.27	$0.10	$0.35	$0.50	$0.25	$0.26	$0.00	$0.40
Adjusted Weighted Average Basic Shares Outstanding	57.07M	57.27M	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M
Adjusted Diluted Earnings per Share	($0.29)	$0.61	$0.24	$0.26	$0.11	$0.35	$0.50	$0.25	$0.24	$0.00	$0.40
Adjusted Weighted Average Diluted Shares Outstanding	57.07M	57.27M	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	57.07M	57.27M	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M
Normalized Net Operating Profit after Tax (NOPAT)	-2.10	56	32	39	18	32	27	30	18	20	41
Normalized NOPAT Margin	-0.76%	20.21%	11.47%	13.56%	6.41%	11.49%	9.55%	11.17%	6.41%	7.67%	15.94%
Pre Tax Income Margin	-10.01%	20.35%	8.84%	7.03%	1.77%	5.16%	3.45%	9.91%	-2.45%	-0.27%	13.82%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	3.85%	0.00%	27.33%	72.88%	48.86%	77.76%	49.00%	49.35%	44.06%	59.62%	65.91%
Augmented Payout Ratio	3.85%	0.00%	27.33%	72.88%	48.86%	77.76%	49.00%	49.35%	44.06%	59.62%	65.91%

Frequently Asked Questions About Embecta's Financials

When does Embecta's fiscal year end?

According to the most recent income statement we have on file, Embecta's financial year ends in September. Their financial year 2024 ended on September 30, 2024.

How has Embecta's net income changed over the last 2 years?

Embecta's net income appears to be on a downward trend, with a most recent value of $78.30 million in 2024, falling from $223.60 million in 2022. The previous period was $70.40 million in 2023. See Embecta's forecast for analyst expectations on what’s next for the company.

What is Embecta's operating income?

Embecta's total operating income in 2024 was $166.80 million, based on the following breakdown:

Total Gross Profit: $735.20 million
Total Operating Expenses: $568.40 million

How has Embecta revenue changed over the last 2 years?

Over the last 2 years, Embecta's total revenue changed from $1.13 billion in 2022 to $1.12 billion in 2024, a change of -0.6%.

How much debt does Embecta have?

Embecta's total liabilities were at $2.02 billion at the end of 2024, a 0.6% decrease from 2023, and a 2.3% increase since 2022.

How much cash does Embecta have?

In the past 2 years, Embecta's cash and equivalents has ranged from $267.50 million in 2024 to $330.90 million in 2022, and is currently $267.50 million as of their latest financial filing in 2024.

How has Embecta's book value per share changed over the last 2 years?

Over the last 2 years, Embecta's book value per share changed from -15.41 in 2022 to -12.80 in 2024, a change of -17.0%.

Related Companies

This page (NASDAQ:EMBC) was last updated on 6/12/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Embecta (EMBC) Financials

Frequently Asked Questions About Embecta's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Embecta (EMBC) Financials

Annual Income Statements for Embecta

Quarterly Income Statements for Embecta

Annual Cash Flow Statements for Embecta

Quarterly Cash Flow Statements for Embecta

Annual Balance Sheets for Embecta

Quarterly Balance Sheets for Embecta

Annual Metrics And Ratios for Embecta

Quarterly Metrics And Ratios for Embecta

Frequently Asked Questions About Embecta's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools